BioSpace News Archive

BioCapital

Supernus to Participate in the 2023 Jefferies London Healthcare Conference

Supernus Pharmaceuticals, Inc. announced that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate in a fireside chat at the Jefferies London Healthcare Conference on Wednesday, November 15, 2023, at 9:00 a.m. ET at the Waldorf Hilton, London, UK.

November 7, 2023
·
3 min read
Business

STERIS Announces Financial Results for Fiscal 2024 Second Quarter

STERIS plc announced financial results for its fiscal 2024 second quarter ended September 30, 2023.

November 7, 2023
·
14 min read
Business

Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update

Pyxis Oncology, Inc. (Nasdaq: PYXS) today announced initiatives to extend its cash runway, reported financial results for the quarter ended September 30, 2023, and provided a corporate update.

November 7, 2023
·
10 min read
Biotech Bay

Geron to Participate at Upcoming Investor Conferences in November 2023

Geron Corporation, a late-stage clinical biopharmaceutical company, announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to present at the following investor conferences.

November 7, 2023
·
1 min read
Qubit Pharmaceuticals honored to announce the arrival of renowned researcher Dr. Alberto Peruzzo as R&D Lead in Quantum Computing

Qubit Pharmaceuticals, a deeptech company specializing in drug discovery through simulation and molecular modeling accelerated by hybrid HPC and quantum computing, announces the arrival of Dr Alberto Peruzzo as Quantum Computing R&D Lead.

November 7, 2023
·
4 min read
Business

Biote Reports Third Quarter 2023 Financial Results

Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced financial results for the third quarter ended September 30, 2023.

November 7, 2023
·
21 min read
Pharm Country

Celldex Therapeutics Announces Pricing of Public Offering of Common Stock - November 08, 2023

Celldex Therapeutics, Inc. announced the pricing of an underwritten public offering of 7,425,000 shares of its common stock at a public offering price of $27.00 per share.

November 7, 2023
·
4 min read
Business

TFF Pharmaceuticals to Hold Third Quarter 2023 Financial and Business Results Conference Call on November 14, 2023Company to hold conference call and webcast on November 14, 2023, at 4:30 PM ET

TFF Pharmaceuticals, Inc. announced that management will host a conference call to discuss the financial results for the third quarter of 2023 and provide an update on recent corporate and clinical developments on Tuesday, November 14, 2023, at 4:30 PM ET.

November 7, 2023
·
5 min read
Genetown

Relay Therapeutics to Participate in Stifel 2023 Healthcare Conference

Relay Therapeutics, Inc. (Nasdaq: RLAY) today announced that management will participate in a fireside chat at the Stifel 2023 Healthcare Conference on Tuesday, November 14, 2023 at 1:50 p.m. ET.

November 7, 2023
·
1 min read
BioCapital

Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference

Acumen Pharmaceuticals, Inc. announced that management will participate in a fireside chat at the Stifel Healthcare Conference on Tuesday, Nov. 14, 2023 at 2:25 p.m. ET.

November 7, 2023
·
1 min read